Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats

Pain

Volumn 90, Issue 1-2, 2001, Pages 57-63

  Zurek, J R ^a   Nadeson, R ^a   Goodchild, C S ^b  

^a MONASH UNIVERSITY   (Australia)

^b Tel: +61 3 9594 5290 ^*  (Australia)

Author keywords

Analgesia; Antinociception; Diabetes; Fentanyl; Neuropathic pain; Opioid; Paw pressure test; Rat; Spinal cord; Tail flick latency

Indexed keywords

FENTANYL; MU OPIATE RECEPTOR; OPIATE; STREPTOZOCIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOSE RESPONSE; ELECTROSTIMULATION; HYPERALGESIA; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANALGESICS, OPIOID; ANIMALS; ANTI-BACTERIAL AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FENTANYL; INJECTIONS, SPINAL; MALE; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SPINAL CORD; STREPTOZOCIN;

EID: 0035252358     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00386-9     Document Type: Article

References (28)

1. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons
2. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
3. Intravenous lidocaine infusion for chronic pain therapy. Israel
4. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats
5. The effect of a peripheral mononeuropathy on immunoreactive (ir)-galanin release in the spinal cord of the rat
6. Streptozocin-induced diabetic rats: Behavioural evidence for a model of chronic pain
7. Noradrenergic innervation to the VMN or MPN is not necessary for lordosis
8. The reorganization of μ opioid receptors in the rat dorsal horn following peripheral axotomy
9. On the mechanism by which midazolam causes spinally mediated analgesia
10. Neuropathic pain of peripheral origin: Advances in pharmacologic treatment
11. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy
12. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy
13. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats
14. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model
15. Diabetic neuropathies
16. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy
17. Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
18. Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy
19. Towards physiologically based treatment of patients with neuropathic pain
20. US government disseminates acute pain treatment guidelines: Will they make a difference
21. A Receptors and spinally-mediated antinociception in rats
22. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury
23. The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions
24. A Method for measurement of analgesic activity of inflamed tissue
25. Reversal by naloxone of spinal antinociceptive effects of fentanyl, ketocyclazocine and midazolam
26. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
27. Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush
28. Ethical guidelines for investigation of experimental pain on conscious animals